Citation Impact
Citing Papers
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.
1990
East-West mortality divide and its potential explanations: proposed research agenda
1996
Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy
1996
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
2010
Inflammation and metabolic disorders
2006 StandoutNature
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
1994
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
1995 Standout
Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations
2000
Understanding the toll of premature death among men in eastern Europe
2001
The metabolic syndrome
2010 Standout
High-Density Lipoprotein as a Therapeutic Target
2007
Should there be a moratorium on the use of cholesterol lowering drugs?
1992
Beyond Cholesterol
1989 Standout
The Value of Lowering Cholesterol after Myocardial Infarction
1990
Occupational class and cause specific mortality in middle aged men in 11 European countries: comparison of population based studies Commentary: Unequal inequalities across Europe
1998
Diagnostic Criteria and Quality Control of the Registration of Stroke Events in the MONICA Project
1988
The Helsinki Heart Study: an 8.5‐year safety and mortality follow‐up
1994
Intraventricular conduction delay: a prognostic marker in chronic heart failure
1999
Normal limits of the electrocardiogram in Chinese subjects
2002
Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
1992 StandoutNature
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
1998 Standout
Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence.
2003 Standout
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
1990 StandoutNature
Electrocardiographic Diagnosis of Evolving Acute Myocardial Infarction in the Presence of Left Bundle-Branch Block
1996
Sick individuals and sick populations
2001 Standout
Might treatment of hypercholesterolaemia increase non-cardiac mortality?
1991
Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)
1991
Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland
1994
Protective and Damaging Effects of Stress Mediators
1998 Standout
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
2004 Standout
Socioeconomic Inequalities in Health in 22 European Countries
2008 Standout
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
1994 Standout
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
2007 Standout
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Atherosclerosis — An Inflammatory Disease
1999 Standout
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Insulin resistance and atherosclerosis
2006
Usefulness of QRST time-integral values of 12-lead electrocardiograms in diagnosing healed myocardial infarction complicated by left bundle branch block
1991 StandoutNobel
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
2004
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Atherosclerosis
2000 StandoutNature
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
Serial electrocardiographic changes in idiopathic dilated cardiomyopathy confirmed at necropsy
1988
Hypertriglyceridemia, Atherogenic Dyslipidemia, and the Metabolic Syndrome
1998
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Atherosclerosis
2001 Standout
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
1991 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Recent advances in diabetic retinopathy
1981
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.
1994 Standout
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
2009
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 Standout
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
2004 Standout
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma.
1995
Total Synthesis of α-Pyrone Meroterpenoids, Novel Bioactive Microbial Metabolites
2005 StandoutNobel
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Stroke Incidence, Case Fatality, and Mortality in the WHO MONICA Project
1995
Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans
1983
Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
1988
Genetic aspects of arteriosclerosis.
1986
An overview of randomized trials of rehabilitation with exercise after myocardial infarction.
1989
Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome?
2007
Strategy of prevention: lessons from cardiovascular disease.
1981
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
1994
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
1986 Standout
Discussion
1999
The Metabolic Syndrome
2008 Standout
Myopathy and Rhabdomyolysis Associated With Lovastatin-Gemfibrozil Combination Therapy
1990
Comparability of M mode echocardiographic long axis and short axis left ventricular function derivatives.
1986
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
Cholesterol Reduction Yields Clinical Benefit
1998
Heart Rate Variability
1996 Standout
Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome.
1992
DIETARY FATS AND CORONARY HEART DISEASE: UNFINISHED BUSINESS
1979
Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays.
1980
Gemfibrozil in the Treatment of Dyslipidaemia A 5‐year follow‐up study
1982
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
2009 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Cholesterol Reduction Yields Clinical Benefit
1995
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
1988 Standout
Works of Z Písa being referenced
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
1978
Criteria for intraventricular conduction disturbances and pre-excitation
1985
[Trends in body weight in the population of the Czech Republic].
1990
Recent trends in cardiovascular disease mortality in 27 industrialized countries.
1985
Report of the Joint International Society and Federation of Cardiology /World Health Organization Task Force on Recommendations for Standardization of Measurements from M-mode Echocardiograms.
1984
Political changes and trends in cardiovascular risk factors in the Czech Republic, 1985-92.
1997
Trends in cardiovascular disease mortality in industrialized countries since 1950.
1988
Rehabilitation and Secondary Prevention of Patients after Acute Myocardial Infarction
2015
Trends of mortality from ischaemic heart disease and other cardiovascular diseases in 27 countries, 1968-1977.
1982